Privacy Policy
Signals Blog

Contributors

Categories

Can COVID-19 be a shot in the arm for cell and gene therapy?

Phil Vanek is responsible for technical due diligence and evaluation of potential investments, as well as guiding operational, R&D and strategic initiatives carried out at portfolio companies. An entrepreneurial and strategic international business leader, Phil...

Right Turn: Combatting disinformation and misinformation

He’s been coming into your home for years, via the television airwaves, so that familiarity probably makes you feel like you know him. Well, I do. I met Ali Velshi before he became The Ali Velshi. We are both from Toronto and met on a special council of high school...

What’s COVID-19 doing to Australian Biotech?

Prof. Richard Boyd (Monash University) is a co-founder and Chief Scientific Officer of Cartherics Pty. Ltd., a young Melbourne–based immunotherapy biotechnology company that combines T cells, NK cells, genetic engineering and stem cells to “supercharge” the immune...

Right Turn: Revisiting stem cell tourism

Are you the type of traveller who finds a destination you love and you keep returning to it every chance you get? That’s not me. I can appreciate that with a limited number of vacation days and a limited budget, there is something to be said for sticking with the...